took over as Managing Director of Max Planck Innovation on December 1, 2005. After joining the company in 1991 he was initially responsible for inventor support and technology transfer in the life-science sector. Later, he took over as head of the patent and licensing group.
Jörn Erselius studied biology at Heidelberg University (focus: microbiology and molecular genetics) and wrote his diploma thesis at the University's Centre for Molecular Biology (ZMBH) on tissue-specific transcription-control elements (promoters, enhancers) of viruses. His thesis at the Max Planck Institute for Biophysical Chemistry in Göttingen (Dept. Prof. Dr Peter Gruss) focused on the isolation and characterization of developmental control genes in mice.
From February 2003 to July 2004 he completed a Master of Business Administration (MBA) focusing on Management at the University of Applied Sciences, Deggendorf. His MBA thesis dealt with "Patenting Biotechnology Inventions – Current Status in Europe and the US".
is authorized representative ("Prokurist") and member of the General Management of Max Planck Innovation. Among others, he acts for the managing director during his absence and is responsible for the spin off activities and the portfolio management.
He has coached and consulted numerous start-up companies during their founding and early stages. In addition, he is a member of the supervisory board of a number of start-ups and an incubator.
Following his diploma in business economics (Ludwig Maximilians University Munich) he was Product Manager Peripheral Products at Hewlett-Packard and coordinated the activities of all product managers for the Hewlett-Packard product portfolio, with a total sales volume in excess of €130m.
Ulrich Mahr joined Max Planck Innovation in July 1998.